“We’ll quickly reveal risk evaluation result on Chinese Valsartan”
The Ministry of Food and Drug Safety(MFDS) has already created a bill to evaluate N-Nitrosodimethylamine(NDMA) in antihypertensives with Chinese Valsartan, and was planning to reveal the evaluation result soon.
The MFDS refuted some media’s reports saying that it would be difficult to find out ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.